eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | small cell carcinoma |
| Comorbidity | C0220650|brain metastases |
| Sentences | 47 |
| PubMedID- 25347291 | Whole brain radiotherapy plus concurrent chemotherapy in non-small cell lung cancer patients with brain metastases: a meta-analysis. |
| PubMedID- 26359696 | Objective: we used brain radiotherapy as a surrogate for the presence of brain metastases in patients with non-small cell lung cancer (nsclc) to determine the prevalence of brain metastases using the surveillance epidemiology and end results database. |
| PubMedID- 26218580 | Radiation-refractory brain metastases in patients with non-small cell lung cancer. |
| PubMedID- 26275366 | Delayed leukoencephalopathy of non-small cell lung cancer patients with brain metastases underwent whole brain radiation therapy. |
| PubMedID- 26310285 | Herein, we conducted a self-controlled study to evaluate the effect of wbrt on the permeability of bbb in non-small cell lung cancer (nsclc) patients with brain metastases (bm). |
| PubMedID- 25031274 | Background: median survival of non-small cell lung cancer (nsclc) patients with brain metastases is poor. |
| PubMedID- 24904894 | Outcome of surgical resection of symptomatic cerebral lesions in non-small cell lung cancer patients with multiple brain metastases. |
| PubMedID- 21574647 | Using a unique study set of 42 brain metastases from patients with breast or nonsmall cell lung cancer (nsclc), the phosphorylation/activation states of 128 key signaling proteins involved in cancer signaling were measured in laser capture microdissected tumor epithelium using reverse phase protein microarray (rpma) technology. |
| PubMedID- 20395118 | The management of brain metastases in patients with non-small cell lung cancer-is it time to go back to the drawing board. |
| PubMedID- 24725335 | Purpose: we intended to identify risk factors that affect brain metastases (bm) in patients with locally advanced non-small cell lung cancer (la-nsclc) receiving definitive radiation therapy, which may guide the choice of selective prevention strategies. |
| PubMedID- 22933980 | Outcome of small cell lung cancer (sclc) patients with brain metastases in a routine clinical setting. |
| PubMedID- 21972711 | [the role of surgical treatment of primary non-small cell lung cancer with synchronous brain metastases]. |
| PubMedID- 22678505 | A 74-year-old diabetic patient who had a history of non-small cell lung cancer with brain metastases and subsequent treatment with srs, presented with a focal lesion in the left centrum semiovale with progressively worsening edema. |
| PubMedID- 24310312 | The outcome of bifocal surgical resection in non-small cell lung cancer with synchronous brain metastases: results of a single center retrospective study. |
| PubMedID- 21317753 | High-dose erlotinib for refractory brain metastases in a patient with relapsed non-small cell lung cancer. |
| PubMedID- 26520640 | We prospectively addressed whether egfr and kras mutations, eml4-alk, ros1 and ret rearrangements, or wild-type (wt), affects radiosurgery outcomes and overall survival (os) in non-small cell lung cancer (nsclc) patients with brain metastases (bm). |
| PubMedID- 25628027 | Squamous cell histology was associated with worse prognosis after resection of brain metastases in patients with non-small cell lung cancer. |
| PubMedID- 23021771 | Miliary brain metastases in 2 cases with advanced non-small cell lung cancer harboring egfr mutation during gefitinib treatment. |
| PubMedID- 25208818 | The aim of this study was to explore prognostic factors for non-small cell lung cancer (nsclc) patients with brain metastases (bm) on the basis of egfr mutation status. |
| PubMedID- 20591632 | Aims: to study various prognostic factors affecting outcome and to validate radiation therapy oncology group recursive partitioning analysis (rpa) class in non-small cell lung cancer (nsclc) with brain metastases treated with short-course accelerated radiotherapy (scar). |
| PubMedID- 22335887 | Although the presence of epidermal growth factor receptor (egfr) mutation and good response to gefitinib have been reported in non-small cell lung cancer (nsclc) patients with miliary brain metastases, the influence of the egfr mutations on the radiographic features remains unclear. |
| PubMedID- 25842091 | Treatment and control of brain metastases are important in patients with non-small cell lung cancer (nsclc). |
| PubMedID- 25925626 | Another trial84 examined the use of primary chemotherapy for newly diagnosed non-small cell lung cancer with synchronous brain metastases (with delayed wbrt at brain relapse) versus wbrt administered first. |
| PubMedID- 19592127 | Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases. |
| PubMedID- 21697413 | Conclusion: radiobiological models suggest that if there is a non-uniform distribution of microscopic brain metastases in patients with small cell lung cancer, higher population-based metastasis-free rates might be achievable with non-uniform irradiation compared with the same integral whole-brain dose delivered as a uniform prescription. |
| PubMedID- 23518381 | Screening for brain metastases in patients with stage iii non-small cell lung cancer: is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain. |
| PubMedID- 22818415 | This study undertook to assess the factors affecting the risk of brain metastases in patients with stage i-iii sclc after surgical resection. |
| PubMedID- 19960229 | Their stated goal was to evaluate the role of wbrt in sclc patients with brain metastases. |
| PubMedID- 21792167 | Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience. |
| PubMedID- 20728237 | Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase ii study of the gruppo oncologico italia meridionale (goim 2603). |
| PubMedID- 19962229 | Conclusion: in patients with brain metastases due to sclc, short-course wbrt with 5x4gy provided similar outcomes as 10x3gy and appears preferable, particularly for patients with poor estimated survival. |
| PubMedID- 23958057 | High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases. |
| PubMedID- 24197981 | Egfr mutation status and its impact on survival of chinese non-small cell lung cancer patients with brain metastases. |
| PubMedID- 25565443 | brain metastases in patients with alk+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden. |
| PubMedID- 22818215 | A 69 year old lady has an extensive small cell lung cancer with newly diagnosed brain metastases. |
| PubMedID- 23392751 | [chemotherapy for small cell lung cancer with brain metastases]. |
| PubMedID- 23376611 | Bevacizumab is now allowed for non-small cell lung cancer (nsclc) patients with brain metastases and non-squamous histology. |
| PubMedID- 22613339 | [progress of treatments in non-small cell lung cancer with brain metastases]. |
| PubMedID- 21924038 | The aim of this study is to explore prognostic factors in non-small cell lung cancer (nsclc) in patients with brain metastases diagnosed by constrast-enhanced mri after whole brain radiotherapy. |
| PubMedID- 24647424 | We found a strong netrin-1 upregulation especially in brain metastases of lung carcinomas (nsclc and sclc) as compared to normal lung tissue (figure s1). |
| PubMedID- 24606446 | Background: the incidence of brain metastases (bm) varies in patients with non-small cell lung cancer (nsclc), calls into question the value of prophylactic cranial irradiation (pci). |
| PubMedID- 24577133 | Background: survival upon diagnosis of brain metastases (bm) in patients with non-small cell lung cancer (nsclc) is highly variable and established prognostic scores do not include tissue-based parameters. |
| PubMedID- 25583566 | Egfr tyrosine kinase inhibitors versus cranial radiation therapy for egfr mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis. |
| PubMedID- 24256883 | Survival and treatment options are limited for patients with brain metastases arising from non-small cell lung cancer (nsclc). |
| PubMedID- 22613338 | Background and objective: the aim of this study is to evaluate the efficacy of selected arterial infusion chemotherapy in treating non-small cell lung cancer (nsclc) with multiple brain metastases and corresponding factors to influencing prognosis. |
| PubMedID- 20658721 | Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors. |
| PubMedID- 20009927 | Multimodality management of non-small cell lung cancer patients with brain metastases. |
Page: 1